Htg Molecular Diagnostics Inc (HTGM) Return on Equity ROE from the first quarter 2023 to first quarter 2022 and annually, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Htg Molecular Diagnostics Inc  (NASDAQ: HTGM)

Htg Molecular Diagnostics Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Htg Molecular Diagnostics Inc in the first quarter 2023?
Htg Molecular Diagnostics Inc recorded a cumulative net loss of $-20 million during 12 months ending in the first quarter 2023, resulting in a negative return on equity (ROE) of -637.5%.

Within the Laboratory Analytical Instruments industry 28 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2022 from 4128 to 4217.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change -95.79 % -48.16 % -91.88 % -69.8 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -20 -22 -22 -22 -19
Return On Equity (TTM) -637.5 % -368.53 % -310.66 % -209.54 % -136.7 %
HTGM's Total Ranking # 4217 # 4128 # 0 # 0 # 0
Equity (TTM) in Millions 0 5 1 6 11
Seq. Equity Change -91.2 % 346.19 % -78.3 % -50.57 % 8.35 %
Seq. Net Income Change - - - - -

Back to HTGM Management Effectiveness >> HTGM's 5 Years Annual ROE >> Compare HTGM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 29
Sector # 894
Overall # 4217

Return On Equity Statistics
High Average Low
-64.48 %
-228.01 %
-1537.67 %
(Dec 31 2018)   (Dec 31 2016)





HTGM Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 5 10 14 24 21
Y / Y Equity Change -48.16 % -28.2 % -39.57 % 13.64 % -
Net Income in Millions -22 -17 -21 -19 -16
Y / Y Net Income Change - - - - -
Return On Equity -400.51 % -164.86 % -144.08 % -80.51 % -78.01 %

Back to HTGM Management Effectiveness >> HTGM's 5 Years Annual ROE >> Compare HTGM ROE to its Competitors




More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HTGM's' Return on Equity at Yahoo Finance
HTGM's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HTGM's Competitors
Subscribers only: Roe for Htg Molecular Diagnostics Inc's Suppliers
Subscribers only: Return On Equity for HTGM's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.